We are studying whether additional cycles of Lutathera® can help patients with new progression of intestinal well-differentiated neuroendocrine tumors. This trial compares the treatment to active monitoring to see which approach is more effective.
Health conditions and diseases that the clinical trial is designed to study and treat.
Neuroendocrine tumors (NETs) are a diverse group of tumors that originate from neuroendocrine cells, which are found throughout the body. These tumors can occur in various organs, including the pancreas, lungs, and gastrointestinal tract, and may cause symptoms depending on their location and hormone production.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.